REPL logo

Replimune (REPL) Cash From Financing

Annual CFF

$16.28 M
-$295.02 M-94.77%

31 March 2024

REPL Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

-$39.00 K
-$96.68 M-100.04%

30 September 2024

REPL Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$111.34 M
-$477.00 K-0.43%

30 September 2024

REPL TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

REPL Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-94.8%-108.9%-59.2%
3 y3 years-95.6%-103.4%-58.0%
5 y5 years-83.9%-100.4%+1017.6%

REPL Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-95.6%+146.8%-100.0%+70.0%-64.3%+1587.5%
5 y5 years-95.6%+146.8%-100.0%+70.0%-70.1%+1587.5%
alltimeall time-95.6%+146.8%-100.0%+80.0%-70.1%

Replimune Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$39.00 K(-100.0%)
$111.34 M(-0.4%)
June 2024
-
$96.64 M(<-9900.0%)
$111.81 M(+586.7%)
Mar 2024
$16.28 M(-94.8%)
-$130.00 K(-100.9%)
$16.28 M(-0.3%)
Dec 2023
-
$14.87 M(+3295.0%)
$16.34 M(-94.0%)
Sept 2023
-
$438.00 K(-60.4%)
$272.90 M(-2.5%)
June 2023
-
$1.10 M(-1535.1%)
$279.89 M(-10.1%)
Mar 2023
$311.30 M(+4618.1%)
-$77.00 K(-100.0%)
$311.30 M(-0.1%)
Dec 2022
-
$271.44 M(+3556.7%)
$311.74 M(+604.1%)
Sept 2022
-
$7.42 M(-77.2%)
$44.27 M(+16.5%)
June 2022
-
$32.52 M(+8959.1%)
$38.00 M(+475.9%)
Mar 2022
$6.60 M(-98.2%)
$359.00 K(-91.0%)
$6.60 M(-6.1%)
Dec 2021
-
$3.97 M(+245.1%)
$7.02 M(-97.4%)
Sept 2021
-
$1.15 M(+2.7%)
$265.25 M(+0.4%)
June 2021
-
$1.12 M(+42.7%)
$264.07 M(-29.1%)
Mar 2021
$372.46 M
$785.00 K(-99.7%)
$372.46 M(+0.2%)
DateAnnualQuarterlyTTM
Dec 2020
-
$262.20 M(<-9900.0%)
$371.71 M(+86.0%)
Sept 2020
-
-$35.00 K(-100.0%)
$199.88 M(-4.7%)
June 2020
-
$109.51 M(>+9900.0%)
$209.66 M(+109.3%)
Mar 2020
$100.17 M(-1.2%)
$34.00 K(-100.0%)
$100.17 M(-0.0%)
Dec 2019
-
$90.36 M(+826.8%)
$100.17 M(+905.6%)
Sept 2019
-
$9.75 M(>+9900.0%)
$9.96 M(-90.2%)
June 2019
-
$18.00 K(-56.1%)
$101.60 M(+0.2%)
Mar 2019
$101.39 M(+85.2%)
$41.00 K(-73.2%)
$101.39 M(+0.0%)
Dec 2018
-
$153.00 K(-99.8%)
$101.35 M(+0.2%)
Sept 2018
-
$101.39 M(<-9900.0%)
$101.20 M(+85.5%)
June 2018
-
-$195.00 K(<-9900.0%)
$54.56 M(-0.4%)
Mar 2018
$54.75 M(+265.0%)
$0.00(0.0%)
$54.75 M(0.0%)
Dec 2017
-
$0.00(-100.0%)
$54.75 M(0.0%)
Sept 2017
-
$54.75 M(>+9900.0%)
$54.75 M(>+9900.0%)
June 2017
-
$0.00
$0.00
Mar 2017
$15.00 M
-
-

FAQ

  • What is Replimune annual cash flow from financing activities?
  • What is the all time high annual CFF for Replimune?
  • What is Replimune annual CFF year-on-year change?
  • What is Replimune quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Replimune?
  • What is Replimune quarterly CFF year-on-year change?
  • What is Replimune TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Replimune?
  • What is Replimune TTM CFF year-on-year change?

What is Replimune annual cash flow from financing activities?

The current annual CFF of REPL is $16.28 M

What is the all time high annual CFF for Replimune?

Replimune all-time high annual cash flow from financing activities is $372.46 M

What is Replimune annual CFF year-on-year change?

Over the past year, REPL annual cash flow from financing activities has changed by -$295.02 M (-94.77%)

What is Replimune quarterly cash flow from financing activities?

The current quarterly CFF of REPL is -$39.00 K

What is the all time high quarterly CFF for Replimune?

Replimune all-time high quarterly cash flow from financing activities is $271.44 M

What is Replimune quarterly CFF year-on-year change?

Over the past year, REPL quarterly cash flow from financing activities has changed by -$477.00 K (-108.90%)

What is Replimune TTM cash flow from financing activities?

The current TTM CFF of REPL is $111.34 M

What is the all time high TTM CFF for Replimune?

Replimune all-time high TTM cash flow from financing activities is $372.46 M

What is Replimune TTM CFF year-on-year change?

Over the past year, REPL TTM cash flow from financing activities has changed by -$161.56 M (-59.20%)